rs10492497

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001845.6(COL4A1):​c.2194-98A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0752 in 1,537,726 control chromosomes in the GnomAD database, including 4,688 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.076 ( 437 hom., cov: 33)
Exomes 𝑓: 0.075 ( 4251 hom. )

Consequence

COL4A1
NM_001845.6 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -2.40

Publications

10 publications found
Variant links:
Genes affected
COL4A1 (HGNC:2202): (collagen type IV alpha 1 chain) This gene encodes a type IV collagen alpha protein. Type IV collagen proteins are integral components of basement membranes. This gene shares a bidirectional promoter with a paralogous gene on the opposite strand. The protein consists of an amino-terminal 7S domain, a triple-helix forming collagenous domain, and a carboxy-terminal non-collagenous domain. It functions as part of a heterotrimer and interacts with other extracellular matrix components such as perlecans, proteoglycans, and laminins. In addition, proteolytic cleavage of the non-collagenous carboxy-terminal domain results in a biologically active fragment known as arresten, which has anti-angiogenic and tumor suppressor properties. Mutations in this gene cause porencephaly, cerebrovascular disease, and renal and muscular defects. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2014]
COL4A1 Gene-Disease associations (from GenCC):
  • brain small vessel disease 1 with or without ocular anomalies
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: G2P, Ambry Genetics, PanelApp Australia, Orphanet, Genomics England PanelApp
  • autosomal dominant familial hematuria-retinal arteriolar tortuosity-contractures syndrome
    Inheritance: AD Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet, Ambry Genetics
  • microangiopathy and leukoencephalopathy, pontine, autosomal dominant
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
  • familial porencephaly
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • pontine autosomal dominant microangiopathy with leukoencephalopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • retinal arterial tortuosity
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • muscular dystrophy-dystroglycanopathy, type A
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BP6
Variant 13-110179519-T-C is Benign according to our data. Variant chr13-110179519-T-C is described in ClinVar as Benign. ClinVar VariationId is 1293322.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.113 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
COL4A1NM_001845.6 linkc.2194-98A>G intron_variant Intron 29 of 51 ENST00000375820.10 NP_001836.3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
COL4A1ENST00000375820.10 linkc.2194-98A>G intron_variant Intron 29 of 51 1 NM_001845.6 ENSP00000364979.4 P02462-1

Frequencies

GnomAD3 genomes
AF:
0.0759
AC:
11558
AN:
152180
Hom.:
437
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0761
Gnomad AMI
AF:
0.0395
Gnomad AMR
AF:
0.0871
Gnomad ASJ
AF:
0.0199
Gnomad EAS
AF:
0.120
Gnomad SAS
AF:
0.0646
Gnomad FIN
AF:
0.0924
Gnomad MID
AF:
0.0348
Gnomad NFE
AF:
0.0716
Gnomad OTH
AF:
0.0784
GnomAD4 exome
AF:
0.0752
AC:
104134
AN:
1385428
Hom.:
4251
AF XY:
0.0744
AC XY:
51587
AN XY:
693370
show subpopulations
African (AFR)
AF:
0.0758
AC:
2418
AN:
31906
American (AMR)
AF:
0.119
AC:
5242
AN:
43998
Ashkenazi Jewish (ASJ)
AF:
0.0169
AC:
431
AN:
25546
East Asian (EAS)
AF:
0.138
AC:
5395
AN:
39236
South Asian (SAS)
AF:
0.0673
AC:
5665
AN:
84134
European-Finnish (FIN)
AF:
0.0878
AC:
4538
AN:
51674
Middle Eastern (MID)
AF:
0.0220
AC:
124
AN:
5648
European-Non Finnish (NFE)
AF:
0.0731
AC:
76390
AN:
1045374
Other (OTH)
AF:
0.0679
AC:
3931
AN:
57912
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
5018
10036
15053
20071
25089
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2844
5688
8532
11376
14220
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0760
AC:
11570
AN:
152298
Hom.:
437
Cov.:
33
AF XY:
0.0777
AC XY:
5783
AN XY:
74466
show subpopulations
African (AFR)
AF:
0.0762
AC:
3166
AN:
41564
American (AMR)
AF:
0.0870
AC:
1331
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.0199
AC:
69
AN:
3472
East Asian (EAS)
AF:
0.121
AC:
625
AN:
5184
South Asian (SAS)
AF:
0.0644
AC:
311
AN:
4826
European-Finnish (FIN)
AF:
0.0924
AC:
981
AN:
10616
Middle Eastern (MID)
AF:
0.0408
AC:
12
AN:
294
European-Non Finnish (NFE)
AF:
0.0717
AC:
4874
AN:
68018
Other (OTH)
AF:
0.0781
AC:
165
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
570
1140
1711
2281
2851
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
140
280
420
560
700
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0712
Hom.:
781
Bravo
AF:
0.0779
Asia WGS
AF:
0.0970
AC:
336
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jun 26, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.89
CADD
Benign
0.21
DANN
Benign
0.29
PhyloP100
-2.4
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs10492497; hg19: chr13-110831866; COSMIC: COSV65430829; API